miR-203与miR-205表达模式可识别皮肤鳞癌预后亚组
结果显示miR-205与不良预后病理特征及局部复发相关,miR-203与良好预后特征相关,两者表达模式多互斥,并可据此将患者分为三个预后不同的聚类。
要点
- miR-205表达与促结缔组织增生、神经周围侵犯和浸润性生长等不良预后特征相关。
- miR-203主要表达于高分化区域,与良好预后特征相关,在浸润前沿少表达。
- 基于miR-203和miR-205表达及病理特征可识别三个预后不同的患者聚类。
核心结论
- miR-205和miR-203在人CSCC中倾向于呈现互斥的表达模式。
- miR-205和miR-203可作为CSCC的预后标志物。
研究设计与样本
- 先在小鼠皮肤癌细胞系面板中鉴定CSCC进展不同阶段的差异miRNA表达模式,再选择miR-205和miR-203评估其与人CSCC临床预后及演化的关联。
主要发现
- miR-205表达于具有促结缔组织增生、神经周围侵犯和浸润性生长模式等不良预后病理特征的肿瘤。
- miR-205主要表达于未分化区域和浸润前沿,与局部复发及总体临床不良演化事件发生相关。
- 在多分类逻辑回归模型中,miR-205表达是被选为预测临床不良演化事件的独立变量。
- miR-203主要表达于具有良好预后特征的肿瘤,主要存在于高分化区域,在浸润前沿少表达。
- 利用逻辑双标图基于miR-203和miR-205表达及病理肿瘤特征识别出三个预后不同的患者聚类。
临床怎么用
- 可考虑将miR-205和miR-203表达检测用于CSCC预后评估,辅助识别高风险患者。
- miR-205高表达尤其位于浸润前沿或未分化区域时提示不良预后,需加强随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cutaneous squamous cell carcinoma (CSCC) is the second most widespread cancer in humans and its incidence is rising. These tumours can evolve as diseases of poor prognosis, and therefore it is important to identify new markers to better predict its clinical evolution. OBJECTIVES: We aimed to identify the expression pattern of microRNAs (miRNAs or miRs) at different stages of skin cancer progression in a panel of murine skin cancer cell lines. Owing to the increasing importance of miRNAs in the pathogenesis of cancer, we considered the possibility that miRNAs could help to define the prognosis of CSCC and aimed to evaluate the potential use of miR-203 and miR-205 as biomarkers of prognosis in human tumours. METHODS: Seventy-nine human primary CSCCs were collected at the University Hospital of Salamanca in Spain. We identified differential miRNA expression patterns at different stages of CSCC progression in a well-established panel of murine skin cancer cell lines, and then selected miR-205 and miR-203 to evaluate their association with the clinical prognosis and evolution of human CSCC. RESULTS: miR-205 was expressed in tumours with pathological features recognized as indicators of poor prognosis such as desmoplasia, perineural invasion and infiltrative growth pattern. miR-205 was mainly expressed in undifferentiated areas and in the invasion front, and was associated with both local recurrence and the development of general clinical events of poor evolution. miR-205 expression was an independent variable selected to predict events of poor clinical evolution using the multinomial logistic regression model described in this study. In contrast, miR-203 was mainly expressed in tumours exhibiting the characteristics associated with a good prognosis, was mainly present in well-differentiated zones, and rarely expressed in the invasion front. Therefore, the expression and associations of miR-205 and miR-203 were mostly mutually exclusive. Finally, using a logistic biplot we identified three clusters of patients with differential prognosis based on miR-203 and miR-205 expression, and pathological tumour features. CONCLUSIONS: miR-205 and miR-203 tended to exhibit mutually exclusive expression patterns in human CSCC. This work highlights the utility of miR-205 and miR-203 as prognostic markers in CSCC.
引用
- Cañueto J, Cardeñoso-Álvarez E, García-Hernández JL, et al. MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma. Br J Dermatol. 2017. PMID: 27943259. doi:10.1111/bjd.15236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。